June 2015 Newsletter
16th World Conference on Lung Cancer is only 75 Days Away - The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied health professionals, advocates and patients. View Details
Kool & The Gang to Headline WCLC 2015 Gala Dinner
Fun Walk – Pancake Breakfast at the World Conference on Lung Cancer
GAIN Programs - United States Locations
Active Members have been sent notice and instructions via email for the IASLC Board of Directors Election on June 11, 2015. The email came from the following email name and address: "IASLC Election Coordinator <firstname.lastname@example.org>." Only active members who paid dues by May 20, 2015 are eligible to vote. The election will end on July 16th, 2015. If you don't see the email announcement on or around June 11, 2015, please check your spam folder or contact Pia Hirsch at email@example.com.
July 2015: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present this feature each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time at the time of print. The articles below from the July issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
We highlight three articles on very different aspects of lung cancer in the July issue of the Journal. As investigators and clinicians in lung cancer know, the very useful 7th edition of the TNM classification for lung cancer is still based on anatomical information. The ongoing work by the IASLC staging committee, which will culminate in the publication of the 8th edition, is evaluating other prognostic markers including histology, tumor markers and molecular genetic factors.
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
The first highlighted article is from the IASLC staging committee and is authored by Rami-Porta and colleagues and it discusses revisions of the T descriptors which will be included in the new edition of the TNM lung cancer classification.
Hormone use and the risk of lung cancer in women continues to be an important area of research. Schwartz et al describes epidemiologic data on this subject.
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients
Finally, Koenig et al suggest that amplicon parallel sequencing improves the diagnostic accuracy of aberrant molecular events in NSCLC.
Invite Your Colleagues to Join IASLC!
Thanks for your membership in IASLC and your support in growing our global team! Invite a Colleague Now
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
WCLC 2015: Free Attendance for Patients/Survivors!
Over this life changing weekend, survivors, patients, caregivers, advocates and healthcare professionals will learn how to bring the lung cancer movement to their communities. This year’s Summit is being held in the gorgeous NYC Metro Area from 9/17-9/20. The three days of interactive training sessions will teach you how to inspire change, educate others, and boost your advocacy impact! Learn More
12th International Conference of Asian Clinical Oncology Society (ACOS)
Many cancers are preventable, many are curable and rest are treatable. Asia is the largest continent, houses 60% of world population and has major cancer burden. Asian countries share challenges in terms of cancer types, therefore there is a greater need to collaborate and address the gaps to have better cure and care of cancer patients. Therefore the theme of conference is “Cancer in Asia: Bridging the Gaps”.
The objectives of ACOS includes cancer prevention, epidemiology, statistics, multidisciplinary treatment i.e. surgery, chemotherapy including oriental medicine, radiotherapy, as well as patient care under high grade development of translational research.
The ACOS is the Biennial International Conference, held in one of our various member countries in Asia. Our aim is foster cancer research & treatment in Asia, clinical experience sharing and enhancing professional networks resulting in advancements of data collation and publication to address the needs of oncologists and cancer patients in Asia. Details
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
February 20 - 23 2019Santa Monica, California
April 3 - 5 2019New York, New York
April 10 - 13 2019Geneva, Switzerland